Atlas Trials

A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)

Clinical trial NCT01775761 · COMPLETED

Trial details

NCT number
NCT01775761
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
TTR Cardiomyopathy
Start date
2013-01-01
Primary completion
2013-04-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.